PER — Percheron Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$6.09m
- AU$2.07m
- AU$0.15m
Australia Stock Exchange release from ANTISENSE THERAP : Trading Halt Remains
Australia Stock Exchange release from ANTISENSE THERAP : Quarterly Report and Appendix 4C
Brief: Antisense Therapeutics Ltd Seeks Trading Halt
Australia Stock Exchange release from ANTISENSE THERAP : Trading Halt
Australia Stock Exchange release from ANTISENSE THERAP : Initial Director's Interest Notice
Australia Stock Exchange release from ANTISENSE THERAP : Antisense Therapeutics appoints new Non-Executive Director
Australia's Antisense jumps on upbeat EMA feedback for DMD treatment
Brief: Antisense Therapeutics Says Positive Feedback Received On Paediatric Investigation Plan
Australia Stock Exchange release from ANTISENSE THERAP : Positive feedback received on Paediatric Investigation Plan
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 09:58:50
Australia's Antisense Therapeutics jumps on muscular dystrophy drug potential
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 09:40:17
Australia Stock Exchange release from ANTISENSE THERAP : New data supports ATL1102s broader clinical potential
Australia Stock Exchange release from ANTISENSE THERAP : ANP to present new proteomics data at WMS Congress 2021
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 09:48:24
Brief: Antisense Therapeutics Says FY Net Loss After Tax A$8.1 Mln
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 17:53:50
Australia Stock Exchange release from ANTISENSE THERAP : Appendix 4E and Full Year Statutory Accounts
Australia Stock Exchange release from ANTISENSE THERAP : ANP to participate in development of DMD Guidance for FDA